Natural History of Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: This study follows people who have had, or will soon have, a transplant using stem cells from another person. This is known as an allogeneic hematopoietic stem cell transplant (HSCT). Graft-versus-host disease (cGVHD) can happen after HSCT. cGVHD can cause mouth problems and more serious issues. Researchers want to study changes in the mouth that might indicate cGVHD.

Objective: To identify cGVHD in the mouth and better understand the development, treatment, and progress of post-transplant changes in the mouth.

Eligibility: Adults at least 18 years old who will soon undergo HSCT or have had one in the past 3 years Healthy adults at least 18 years old

Design: All participants will have a screening visit and baseline visit. They will last 60-90 minutes. Over these two visits, participants will have: Medical and dental history Dental exam. Questions about their eating habits and general health Blood drawn through a needle in the arm Vital signs taken Pictures of their mouth and lips taken Questions about their oral health, including about pain, sensitivity, or dryness Saliva samples taken. Participants will spit into a sterile plastic tube. Swabs taken of the mouth and some of the saliva, plaque, and fluid from the spaces between teeth and gums. Participants may also have: A piece of skin taken (biopsy) from the inner lining of the cheeks A piece of skin taken (biopsy) from the lower lip Dental X-rays Urine pregnancy test Most participants will have at least 7 study visits over 3 years. They will meet with a dentist and repeat baseline tests.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

• Subjects in Cohort NT and Cohort PT must satisfy all of the following criteria in order to participate in the study:

‣ Scheduled to undergo allogeneic HSCT at the NIH (Cohort NT) or have already undergone allogeneic HSCT at the NIH or another institution (Cohort PT) and are within 3 years of most recent bone marrow transplant

⁃ Willing to participate in protocol evaluations including saliva collection, oral swab collection, and completion of patient-reported outcome (PRO) forms

⁃ Willing to return to the NIH Dental Clinic for scheduled evaluations

⁃ Be at least 18 years of age at screening

⁃ Be able to understand and provide written informed consent

• Subjects in Cohort HL and Cohort HS must satisfy all of the following criteria in order to participate in the study:

‣ Willing to undergo oral exam and participate in Visit 1 protocol evaluations including saliva collection, oral swab collection and oral biopsies.

⁃ Be at least 18 years of age at screening

⁃ Be able to understand and provide written informed consent

⁃ Potentially be age- and/or sex-matched with a transplant patient

• Subjects in Cohort HL must additionally be willing and able to return to the NIH Dental Clinic for scheduled visits across 1 year and participate in evaluations including saliva collection, oral swab collection, and completion of PRO forms

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Licia R Masuch
licia.masuch@nih.gov
(301) 335-0113
Backup
Jacqueline W Mays, D.D.S.
jacqueline.mays@nih.gov
(301) 496-8800
Time Frame
Start Date: 2018-11-15
Estimated Completion Date: 2026-03-03
Participants
Target number of participants: 500
Treatments
Healthy-controls Longitudinal Cohort
( Cohort HL ; approximate n=20) includes subjects who will participate in up to 4 study visits across 1 year.
Healthy-controls Short-term Cohort
( Cohort HS ; approximate n=80) will participate in a single baseline visit.
New Transplant Cohort
( Cohort NT ; approximate n=300) consists of patients who are scheduled to undergo allogeneic HSCT (under another protocol at the NIH).
Prior Transplant Cohort
( Cohort PT ; approximate n=100) consists of patients who have already undergone allogeneic HSCT.
Sponsors
Leads: National Institute of Dental and Craniofacial Research (NIDCR)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials